Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 18 studies | 46% ± 18% | |
| peripheral blood | 18 studies | 43% ± 14% | |
| intestine | 13 studies | 37% ± 19% | |
| kidney | 9 studies | 43% ± 14% | |
| eye | 8 studies | 36% ± 14% | |
| brain | 7 studies | 29% ± 8% | |
| lymph node | 6 studies | 37% ± 15% | |
| pancreas | 5 studies | 52% ± 25% | |
| bone marrow | 5 studies | 31% ± 13% | |
| liver | 5 studies | 49% ± 21% | |
| placenta | 4 studies | 58% ± 27% | |
| uterus | 4 studies | 60% ± 15% | |
| prostate | 4 studies | 27% ± 9% | |
| breast | 4 studies | 40% ± 10% | |
| adrenal gland | 3 studies | 38% ± 12% | |
| esophagus | 3 studies | 52% ± 28% | |
| skin | 3 studies | 42% ± 12% | |
| thymus | 3 studies | 58% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 4498.76 | 21 / 21 | 100% | 29.50 | 504 / 504 |
| brain | 100% | 5566.75 | 2642 / 2642 | 100% | 24.09 | 705 / 705 |
| esophagus | 100% | 4784.15 | 1445 / 1445 | 100% | 22.22 | 183 / 183 |
| liver | 100% | 2800.25 | 226 / 226 | 100% | 19.75 | 406 / 406 |
| ovary | 100% | 3918.53 | 180 / 180 | 100% | 33.79 | 430 / 430 |
| skin | 100% | 5878.14 | 1809 / 1809 | 100% | 21.55 | 472 / 472 |
| stomach | 100% | 3412.99 | 359 / 359 | 100% | 23.43 | 286 / 286 |
| thymus | 100% | 4316.09 | 653 / 653 | 100% | 25.17 | 605 / 605 |
| uterus | 100% | 4310.55 | 170 / 170 | 100% | 31.19 | 459 / 459 |
| kidney | 100% | 5189.17 | 89 / 89 | 100% | 17.70 | 900 / 901 |
| intestine | 100% | 4419.60 | 966 / 966 | 100% | 25.73 | 526 / 527 |
| prostate | 100% | 4146.78 | 245 / 245 | 100% | 21.89 | 501 / 502 |
| lung | 100% | 4418.15 | 576 / 578 | 100% | 23.28 | 1155 / 1155 |
| breast | 100% | 4566.10 | 459 / 459 | 100% | 26.27 | 1114 / 1118 |
| adrenal gland | 100% | 6224.76 | 258 / 258 | 100% | 27.37 | 229 / 230 |
| pancreas | 98% | 1853.42 | 323 / 328 | 99% | 23.48 | 177 / 178 |
| adipose | 100% | 4781.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5084.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 40.78 | 29 / 29 |
| muscle | 100% | 4556.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4717.36 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.50 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.69 | 1 / 1 |
| heart | 99% | 4755.96 | 853 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 21.01 | 79 / 80 |
| peripheral blood | 99% | 4347.43 | 917 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0019941 | Biological process | modification-dependent protein catabolic process |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
| GO_0008104 | Biological process | protein localization |
| GO_0045116 | Biological process | protein neddylation |
| GO_0030162 | Biological process | regulation of proteolysis |
| GO_0036211 | Biological process | protein modification process |
| GO_0006508 | Biological process | proteolysis |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0031386 | Molecular function | protein tag activity |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NEDD8 |
| Protein name | NEDD8 ubiquitin like modifier NEDD8 (Neddylin) (Neural precursor cell expressed developmentally down-regulated protein 8) (NEDD-8) (Ubiquitin-like protein Nedd8) Neural cell expressed developmentally down-regulated protein 8 |
| Synonyms | |
| Description | FUNCTION: Ubiquitin-like protein which plays an important role in cell cycle control and embryogenesis via its conjugation to a limited number of cellular proteins, such as cullins or p53/TP53 . Attachment of NEDD8 to cullins is critical for the recruitment of E2 to the cullin-RING-based E3 ubiquitin-protein ligase complex, thus facilitating polyubiquitination and proteasomal degradation of cyclins and other regulatory proteins . Attachment of NEDD8 to p53/TP53 inhibits p53/TP53 transcriptional activity . Covalent attachment to its substrates requires prior activation by the E1 complex UBE1C-APPBP1 and linkage to the E2 enzyme UBE2M . . |
| Accessions | ENST00000524927.1 Q96L81 ENST00000396828.8 Q15843 ENST00000643069.2 F8VSA6 ENST00000250495.10 |